Enhancing the Conformational Stability of the cl-Par-4 Tumor Suppressor via Site-Directed Mutagenesis

Samjhana Pandey1, Krishna K Raut2, Andrea M Clark2

  • 1Biomedical Sciences Program, Old Dominion University, Norfolk, VA 23529, USA.

Biomolecules
|May 16, 2023
PubMed

Insights

Prostate apoptosis response-4 (Par-4) is a tumor suppressor. A D313K mutant of cleaved Par-4 (cl-Par-4) stabilizes its structure at lower salt concentrations, aiding cancer research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Intrinsically disordered proteins (IDPs) are crucial in cell signaling, with dysregulation linked to diseases.
  • Prostate apoptosis response-4 (Par-4) is a predominantly IDP and a proapoptotic tumor suppressor, often downregulated in cancers.
  • The active caspase-cleaved fragment of Par-4 (cl-Par-4) exhibits tumor suppressor activity by inhibiting cell survival pathways.

Purpose of the Study:

  • To investigate the structural conformational changes of a site-directed mutant (D313K) of cl-Par-4.
  • To compare the biophysical properties of the D313K mutant with wild-type (WT) cl-Par-4.

Main Methods:

  • Site-directed mutagenesis was used to generate the cl-Par-4 D313K point mutant.
  • The expressed and purified D313K protein was characterized using biophysical techniques.
  • Structural conformation was analyzed in the presence of varying salt concentrations at physiological pH.

Main Results:

  • The D313K mutant attained a stable, compact, helical conformation similar to WT cl-Par-4.
  • This stabilization occurred at approximately half the salt concentration required for WT cl-Par-4.
  • The substitution of an acidic residue with a basic residue at position 313 reduces inter-helical charge repulsion, enhancing structural stability.

Conclusions:

  • The D313K mutation enhances the structural stability of cl-Par-4.
  • This finding provides insights into the structural dynamics of intrinsically disordered proteins and their role in cancer.
  • Understanding these structural properties can inform therapeutic strategies targeting cancer-associated protein dysregulation.